Literature DB >> 14703504

A novel cholesterol stain reveals early neuronal cholesterol accumulation in the Niemann-Pick type C1 mouse brain.

Patrick C Reid1, Naomi Sakashita, Shigeki Sugii, Yoshiko Ohno-Iwashita, Yukiko Shimada, William F Hickey, Ta-Yuan Chang.   

Abstract

Niemann-Pick type C (NPC) is a neurodegenerative disorder characterized by progressive accumulation of cholesterol, gangliosides, and other lipids in the central nervous system and visceral organs. In the NPC1 mouse model, neurodegeneration and neuronal cell loss occur before postnatal day 21. Whether neuronal cholesterol accumulation occurs in vivo before the first signs of neuronal cell loss has not been demonstrated. In this report, we used the NPC1 mouse model and employed a novel cholesterol binding reagent, BC theta, that enabled us to visualize cellular cholesterol accumulation at a level previously unattainable. The results demonstrate the superiority of BC theta staining over conventional filipin staining in confocal microscopy and highlight several new findings. We show that at postnatal day 9, although only mild signs of neurodegeneration are detectable, significant neuronal cholesterol accumulation has already occurred throughout the NPC1 brain. In addition, although NPC1 Purkinje neurons exhibit a normal morphology at day 9, significant cholesterol accumulation within their extensive dendritic trees has occurred. We also show that in the thalamus and cortex of NPC1 mice, activated glial cells first appear at postnatal day 9 and heavily populate by day 22, suggesting that in NPC1 mice, neuronal cholesterol accumulation precedes neuronal injury and neuronal cell loss.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14703504     DOI: 10.1194/jlr.D300032-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  40 in total

1.  Plasticity in membrane cholesterol contributes toward electrical maturation of hearing.

Authors:  Snezana Levic; Ebenezer N Yamoah
Journal:  J Biol Chem       Date:  2010-12-16       Impact factor: 5.157

2.  Attenuation of the lysosomal death pathway by lysosomal cholesterol accumulation.

Authors:  Hanna Appelqvist; Cathrine Nilsson; Brett Garner; Andrew J Brown; Katarina Kågedal; Karin Ollinger
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease.

Authors:  Forbes D Porter; David E Scherrer; Michael H Lanier; S Joshua Langmade; Vasumathi Molugu; Sarah E Gale; Dana Olzeski; Rohini Sidhu; Dennis J Dietzen; Rao Fu; Christopher A Wassif; Nicole M Yanjanin; Steven P Marso; John House; Charles Vite; Jean E Schaffer; Daniel S Ory
Journal:  Sci Transl Med       Date:  2010-11-03       Impact factor: 17.956

4.  Generation of a human neuronal stable cell model for niemann-pick C disease by RNA interference.

Authors:  Laura Rodríguez-Pascau; Maria Josep Coll; Josefina Casas; Lluïsa Vilageliu; Daniel Grinberg
Journal:  JIMD Rep       Date:  2011-11-01

5.  Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C.

Authors:  Sharon Zhou; Cristin Davidson; Robert McGlynn; Gloria Stephney; Kostantin Dobrenis; Marie T Vanier; Steven U Walkley
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

Review 6.  Cholesterol in Niemann-Pick Type C disease.

Authors:  Xiaoning Bi; Guanghong Liao
Journal:  Subcell Biochem       Date:  2010

Review 7.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

8.  GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.

Authors:  Hao Li; Stephen D Turley; Benny Liu; Joyce J Repa; John M Dietschy
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

Review 9.  Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  Orphanet J Rare Dis       Date:  2010-06-03       Impact factor: 4.123

10.  Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1).

Authors:  Brett Tortelli; Hideji Fujiwara; Jessica H Bagel; Jessie Zhang; Rohini Sidhu; Xuntian Jiang; Nicole M Yanjanin; Roopa Kanakatti Shankar; Nuria Carillo-Carasco; John Heiss; Elizabeth Ottinger; Forbes D Porter; Jean E Schaffer; Charles H Vite; Daniel S Ory
Journal:  Hum Mol Genet       Date:  2014-06-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.